A new treatment option for elderly AML patients?November 25, 2014Leukemia, Myelodysplasia, TransplantationAML
FDA grants drug orphan designation for AMLNovember 21, 2014Leukemia, Myelodysplasia, TransplantationPharmacyAML
Inhibitor could transform AML therapy, speaker saysNovember 20, 2014Leukemia, Myelodysplasia, TransplantationAML
Combo can improve survival in certain AML patientsOctober 7, 2014Leukemia, Myelodysplasia, TransplantationAML
Study links gene dysfunction to Fanconi anemia, AMLAugust 26, 2014AnemiaLeukemia, Myelodysplasia, TransplantationAML
Drug on the fast track to treat AMLAugust 16, 2014Leukemia, Myelodysplasia, TransplantationPharmacyAML
Drugs can increase risk of MDS and AMLAugust 7, 2014AnemiaLeukemia, Myelodysplasia, TransplantationAMLMyelodysplastic Syndrome
Inhibitor improves survival in older AML patientsJuly 9, 2014Leukemia, Myelodysplasia, TransplantationAML
Inhibitor shows promise for hematologic disordersJune 24, 2014CythemiasAnemiaLeukemia, Myelodysplasia, TransplantationAMLMyelodysplastic Syndrome
Sequential decitabine, idarubicin combo synergistic in AMLJune 17, 2014Leukemia, Myelodysplasia, TransplantationAML
Team identifies mechanism of resistance in AMLJune 4, 2014Leukemia, Myelodysplasia, TransplantationAML
Drug granted orphan designation for AMLMay 21, 2014Leukemia, Myelodysplasia, TransplantationPharmacyAML
Protein interaction may be therapeutic target for AMLMay 8, 2014Leukemia, Myelodysplasia, TransplantationAML
